Table 2.

Prediction of unfavorable outcome by multivariable modeling of baseline clinical characteristics

	Coef.	Std.Err
Not in remission a N  = 156
	β0=-1.58	0.44
Cumulative active joint count	β1=0.04	0.05
ESR mm/h	β2=0.03	0.02
CRP >10 mg/L	β3=-0.07	0.69
Morning stiffness > 15 min	β4=1.16	0.45
Physician’s global assessment VAS	β5=0.16	0.46
ANA-positive	β6=1.25	0.50
HLA-B27-positive	β7=1.37	0.54
Ankle joint arthritis	β8=1.10	0.49
Functional disability (CHAQ), N  = 141
	β0=-1.68	0.35
Cumulative active joint count	β1=-0.02	0.03
ESR mm/h	β2=0.01	0.01
CRP > 10 mg/L	β3=-0.20	0.63
Morning stiffness > 15 min	β4=1.03	0.42
Physician’s global assessment VAS	β5=-0.40	0.56
Finger joint arthritis	β6=1.21	0.54
Pain VAS	β7 = 0.77	0.40
Functional disability (PhS), N  = 92
	β0=-3.40	0.75
Cumulative active joint count	β1=0.10	0.05
ESR mm/h	β2=0.01	0.02
CRP > 10 mg/L	β3=-2.06	1.28
Morning stiffness > 15 min	β4=1.68	0.80
Physician’s global assessment VAS	β5=-0.71	0.88
Pain VAS	β6=1.30	0.64
Joint damage (JADI-A), N  = 141
	β0=-3.84	0.76
Cumulative active joint count	β1=0.02	0.04
ESR mm/h	β2=0.01	0.02
CRP > 10 mg/l	β3= -0.11	0.83
Morning stiffness > 15 min	β4=-0.59	0.61
Physician’s global assessment VAS	β5=0.28	0.52
Finger joint arthritis	β6=1.84	0.68
Older age at disease onset (years)	β7= 0.16	0.07

Coef. coefficients in the logistic regression, Std.Err. standard error in the coefficients, VAS visual analogue scale, ESR erythrocyte sedimentation rate for an increase in 10 mm/h, CRP C-reactive protein, ANA antinuclear antibody, HLA-B27 human leucocyte antigen

^aNot in remission equals non-achievement of remission off medication